Oct 24, 2024 7:00am EDT XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2024
Oct 18, 2024 4:00pm EDT XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement
Oct 17, 2024 8:00am EDT XORTX Announces Pricing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement
Sep 06, 2024 5:30pm EDT XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders
Sep 03, 2024 12:30pm EDT Independent Proxy Advisory Firm ISS Recommends XORTX Shareholders Vote FOR ALL Proposed Items at the Upcoming Annual and Special Meeting of Shareholders
Aug 29, 2024 7:00am EDT XORTX Highlights Pioneering Research Indicating a Role for Genetic Regulation of Xanthine Oxidase and Therapeutic Targeting of Aberrant Purine Metabolism
Aug 23, 2024 7:00am EDT XORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of Shareholders